Soreide K, Sandvik OM, Soreide JA et al (2016) Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol 40:39–46. https://doi.org/10.1016/j.canep.2015.10.031

Article  PubMed  Google Scholar 

Joensuu H (2006) Gastrointestinal stromal tumor (GIST). Ann Oncol 17(Suppl 10):x280–x286. https://doi.org/10.1093/annonc/mdl274

Article  PubMed  Google Scholar 

Yang DY, Wang X, Yuan WJ et al (2019) Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis. Clin Transl Oncol 21(12):1654–1662. https://doi.org/10.1007/s12094-019-02094-y

Article  PubMed  CAS  Google Scholar 

Joensuu H, Vehtari A, Riihimaki J et al (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13(3):265–274. https://doi.org/10.1016/S1470-2045(11)70299-6

Article  PubMed  Google Scholar 

van der Graaf WTA, Tielen R, Bonenkamp JJ et al (2018) Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era. Br J Surg 105:1020–1027. https://doi.org/10.1002/bjs.10809

Article  PubMed  CAS  Google Scholar 

Sutton TL, Walker BS, Billingsley KG et al (2022) Ten-year survivorship in patients with metastatic gastrointestinal stromal tumors. Ann Surg Oncol 29(11):7123–7132. https://doi.org/10.1245/s10434-022-12063-5

Article  PubMed  PubMed Central  Google Scholar 

Sutton TL, Walker BS, Billingsley KG et al (2021) Disease-free interval is associated with oncologic outcomes in patients with recurrent gastrointestinal stromal tumor. Ann Surg Oncol 28(12):7912–7920. https://doi.org/10.1245/s10434-021-10062-6

Article  PubMed  Google Scholar 

Chen Z, Lin R-M, Bai Y-K et al (2018) Establishment and verification of prognostic nomograms for patients with gastrointestinal stromal tumors: a SEER-based study. BioMed Res Int 2019:8293261. https://doi.org/10.1155/2019/8293261

Article  Google Scholar 

Singer S, Rubin BP, Lux ML et al (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20(18):3898–3905. https://doi.org/10.1200/JCO.2002.03.095

Article  PubMed  CAS  Google Scholar 

Fujimoto Y, Nakanishi Y, Yoshimura K et al (2003) Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 6(1):39–48. https://doi.org/10.1007/s101200300005

Article  PubMed  Google Scholar 

Ijzerman NS, van Werkhoven E, Mohammadi M et al (2022) Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival? ESMO Open 7(6):100649. https://doi.org/10.1016/j.esmoop.2022.100649

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wells G, Shea B, O'Connell D, et al. (2021) The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Verweij J, Casali PG, Zalcberg J et al (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 364:1127–1134. https://doi.org/10.1016/S0140-6736(04)17098-0

Article  PubMed  CAS  Google Scholar 

Patrikidou A, Domont J, Chabaud S et al (2016) Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group. Eur J Cancer 52:173–180. https://doi.org/10.1016/j.ejca.2015.10.069

Article  PubMed  CAS  Google Scholar 

Blanke CD, Rankin C, Demetri GD et al (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626–632. https://doi.org/10.1200/JCO.2007.13.4452

Article  PubMed  CAS  Google Scholar 

Kang HJ, Ryu MH, Kim KM et al (2012) Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GOST): the Korean GIST Study Group (KGSG) study. Acta Oncol 51(4):528–536. https://doi.org/10.3109/0284186X.2011.636753

Article  PubMed  CAS  Google Scholar 

Bauer S, Rutkowski P, Hohenberger P et al (2014) Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib—analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol 40:412–419. https://doi.org/10.1016/j.ejso.2013.12.020

Article  PubMed  CAS  Google Scholar 

Bischof DA, Kim Y, Blazer DG III et al (2014) Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients. J Am Coll Surg 219(3):439–449. https://doi.org/10.1016/j.jamcollsurg.2014.02.037

Article  PubMed  Google Scholar 

Brudvik KW, Patel SH, Roland CL et al (2015) Survival after resection of gastrointestinal stromal tumor and sarcoma liver metastases in 146 patients. J Gastrointest Surg 19(8):1476–1483. https://doi.org/10.1007/s11605-015-2845-9

Article  PubMed  PubMed Central  Google Scholar 

Sato S, Tsujinaka T, Masuzawa T et al (2017) Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry. Surg Today 47(1):58–64. https://doi.org/10.1007/s00595-016-1351-3

Article  PubMed  CAS  Google Scholar 

Shi YN, Li Y, Wang LP et al (2017) Gastrointestinal stromal tumor (GIST) with liver metastases. An 18-year experience from the GIST cooperation group in North China. Medicine 96(46):e8240. https://doi.org/10.1097/MD.0000000000008240

Article  PubMed  PubMed Central  Google Scholar 

Hompland I, Bruland OS, Holmebakk T et al (2017) Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort. Acta Oncol 56(10):1317–1323. https://doi.org/10.1080/0284186X.2017.1330555

Article  PubMed  Google Scholar 

Verboom MC, Kloth JSL, Swen JJ et al (2017) Genetic polymorphysms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib. Eur J Cancer 86:226–232. https://doi.org/10.1016/j.ejca.2017.09.025

Article  PubMed  CAS  Google Scholar 

Ogata K, Kimura A, Nakazawa N et al (2018) Long-term imatinib treatment for patients with unresectable or recurrent gastrointestinal stromal tumors. Digestion 97:20–25. https://doi.org/10.1159/000484102

Article  PubMed  CAS  Google Scholar 

Kim JH, Ryu MH, Yoo C et al (2019) Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: a 14-year, single-center experience. Cancer Med 8:1034–1043. https://doi.org/10.1002/cam4.1994

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hung KD, Van QL, Hoang GN et al (2019) Imatinib mesylate for patients with unresectable or recurrent gastrointestinal stromal tumors: 10-year experience from Vietnam. Cancer Control 26:1–7. https://doi.org/10.1177/1073274819863776

Article  Google Scholar 

Zhang X, Ning L, Hu Y et al (2020) Prognostic factors for primary localized gastrointestinal stromal tumors after radical resection: Sandong gastrointestinal surgery study group. Ann Surg Oncol 27(8):2812–2821. https://doi.org/10.1245/s10434-020-08244-9

Article  PubMed  Google Scholar 

Lv M, Wu C, Zheng Y et al (2014) Incidence and survival analysis of gastrointestinal stromal tumors in Shangai: a population-based study from 2001 to 2010. Gastroenterol Res Pract 2014:834136. https://doi.org/10.1155/2014/834136

Article  PubMed  PubMed Central  Google Scholar 

Rutkowski P, Nowecki ZI, Michej W et al (2007) Risk criteria and prognostic gactors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 14(7):2018–2027. https://doi.org/10.1245/s10434-007-9377-9

Article  PubMed  Google Scholar 

Liu M, Song C, Zhang P et al (2020) A nomogram for predicting cancer-specific survival of patients with gastrointestinal stromal tumors. Med Sci